Carol Feghali-Bostwick, Ph.D.
Carol Feghali-Bostwick, PhD, joined the Division of Rheumatology and Immunology effective October 1, 2013, as the Kitty Trask Holt Endowed Chair and Professor of Medicine. Dr. Feghali-Bostwick earned her Master of Science from the American University of Beirut in Beirut, Lebanon with a major in Microbiology. She completed her PhD in Microbiology and Immunology at Tulane University in New Orleans, LA.
Dr. Feghali-Bostwick leads a team of clinical and basic scientists whose goal is to identify novel targets for therapy and develop new anti-fibrotic strategies for scleroderma and other fibrosing conditions. Dr. Feghali-Bostwick also contributes to the mentoring of young physician and academic scientists.
Dr. Feghali-Bostwick and her team are working on several aspects of scleroderma research. They are 1) identifying the mechanism used by novel factors to trigger fibrosis, 2) examining differences that may explain the occurrence of scleroderma in twins, and 3) conducting studies on a very promising drug which has already shown outstanding results in stopping and even reversing fibrosis in models of scleroderma.
Work in the Feghali-Bostwick laboratory has been supported by grants from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases; SmartState SC Centers of Economic Excellence; and Biogen Idec, MA, Inc.
Dr. Feghali-Bostwick's Curriculum Vitae (PDF Format)*
* Note in order to view this document you will need to have the free Adobe Reader® installed on your computer. More on Adobe Acrobat®.